SciSparc to seek US FDA nod to begin phase IIb trial with SCI-110 to treat Tourette syndrome: Tel Aviv, Israel Monday, July 11, 2022, 16:00 Hrs [IST] SciSparc Ltd., a specialty cl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback